Simon Fredriksson

Simon is continually fascinated by technological innovation that pushes the frontiers of scientific discovery into new and unchartered territories. His deep experience as a life science entrepreneur, researcher, and inventor has spanned from genomics to proteomics research tools. 

Simon was co-Founder, Chief Science Officer, and CEO of Olink AB, which later become Olink Proteomics AB, a publicly traded proteomics company, where he led the development and commercialization of multiple product lines, most notably the Proximity-Extension Assays (PEA) platform for high throughput multiplex protein detection. He served on the boards of Moligo Technologies, Olink AB, Olink Proteomics AB (NASDAQ:OLK), Biolamina AB, Basic Genomics AB, and Cartana AB.

Simon earned his Doctorate in Molecular Medicine from Uppsala University and spent four years in research at Stanford University. His research has been published extensively, and he is an inventor with several patents and patent applications on solution phase Proximity Ligation. He developed homogenous Proximity-Ligation Assay (PLA) technology during his graduate work and has further expanded the technology into a multiplexed protein detection tool for biomarker research. He is also Adjunct Professor of Engineering in Molecular Diagnostics at the Royal Institute of Technology (KTH).